The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Open accessAbstract
Cytokines of the interleukin-1 (IL-1) family, such as IL-1 alpha/beta and IL-18, have important functions in host defense, immune regulation, and inflammation. Insight into their biological functions has led to novel therapeutic approaches to treat human inflammatory diseases. Within the IL-1 family, IL-1 alpha/beta, IL-1Ra, and IL-18 have been matched to their respective receptor complexes and have been shown to have distinct biological functions. The most prominent orphan IL-1 receptor is ST 2. This receptor has been described as a negative regulator of Toll-like receptor-IL-1 receptor signaling, but it also functions as an important effector molecule of T helper type 2 responses. We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST 2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokines from in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UCSC Genome Browser Database
Karolchik, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg129 · Cited by 1,887
Enhanced genome annotation using structural profiles in the program 3D-PSSM 1 1Edited by J. Thornton
Kelley, L. A., MacCallum, R. M., & Sternberg, M. J. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3741 · Cited by 1,468
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Self-citationBoonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F. J., & O’Garra, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4974 · Cited by 1,123
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
Self-citationDunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Touring protein fold space with Dali/FSSP
Holm, L. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.316 · Cited by 663
SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., & Li, X. (2003) · Nature Immunology · doi:10.1038/ni968 · Cited by 606
Self-citationLöhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., & Kamradt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6930 · Cited by 605
Dinarello, C. A. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00023-3 · Cited by 582
Cited by
Items 201–294 of 294
Choi, Y.-S., Choi, H.-J., Min, J.-K., Pyun, B.-J., Maeng, Y.-S., Park, H., Kim, J., Kim, Y.-M., & Kwon, Y.-G. (2009) · Blood · doi:10.1182/blood-2009-02-203372 · Cited by 302
Cells of the synovium in rheumatoid arthritis. Macrophages
Kinne, R. W., Stuhlmüller, B., & Burmester, G.-R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2333 · Cited by 300
Cellular and functional heterogeneity of the airway epithelium
Davis, J. D., & Wypych, T. P. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00370-7 · Cited by 300
Roussel, L., Erard, M., Cayrol, C., & Girard, J. (2008) · EMBO reports · doi:10.1038/embor.2008.145 · Cited by 300
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
Structural Basis of IL-1 Family Cytokine Signaling
Fields, J. K., Günther, S., & Sundberg, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01412 · Cited by 299
TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system
Miao, E. A., Andersen-Nissen, E., Warren, S. E., & Aderem, A. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0078-z · Cited by 297
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Kakkar, R., Hei, H., Dobner, S., & Lee, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298703 · Cited by 297
New fronts emerge in the influenza cytokine storm
Guo, X.-Z. J., & Thomas, P. G. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0636-y · Cited by 297
Immunopathology of chronic rhinosinusitis
Kato, A. (2015) · Allergology International · doi:10.1016/j.alit.2014.12.006 · Cited by 291
IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation
Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., & Liew, F. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000730 · Cited by 291
Toll-like Receptors are Key Participants in Innate Immune Responses
ARANCIBIA, S. A., BELTRÁN, C. J., AGUIRRE, I. M., SILVA, P., PERALTA, A. L., MALINARICH, F., & HERMOSO, M. A. (2007) · Biological Research · doi:10.4067/s0716-97602007000200001 · Cited by 289
Han, H., Roan, F., & Ziegler, S. F. (2017) · Immunological Reviews · doi:10.1111/imr.12546 · Cited by 285
IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals
Ho, L. H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., Okayama, Y., Akira, S., Saito, H., Galli, S. J., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407200 · Cited by 285
RETRACTED: The cytokine interleukin-33 mediates anaphylactic shock
Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y., & Melendez, A. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901206106 · Cited by 285
RetractedIL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Chan, B. C. L., Lam, C. W. K., Tam, L.-S., & Wong, C. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00364 · Cited by 285
IL-1 Family Members in Cancer; Two Sides to Every Story
Baker, K. J., Houston, A., & Brint, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01197 · Cited by 284
Androgen signaling negatively controls group 2 innate lymphoid cells
Laffont, S., Blanquart, E., Savignac, M., Cénac, C., Laverny, G., Metzger, D., Girard, J.-P., Belz, G. T., Pelletier, L., Seillet, C., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161807 · Cited by 282
Weir, R. A. P., Miller, A. M., Murphy, G. E. J., Clements, S., Steedman, T., Connell, J. M. C., McInnes, I. B., Dargie, H. J., & McMurray, J. J. V. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.047 · Cited by 280
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Shaw, J. L., Fakhri, S., Citardi, M. J., Porter, P. C., Corry, D. B., Kheradmand, F., Liu, Y.-J., & Luong, A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2227oc · Cited by 279
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Fahey, E., & Doyle, S. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01426 · Cited by 276
Brough, H. A., Nadeau, K. C., Sindher, S. B., Alkotob, S. S., Chan, S., Bahnson, H. T., Leung, D. Y. M., & Lack, G. (2020) · Allergy · doi:10.1111/all.14304 · Cited by 275
Morita, H., Arae, K., Unno, H., Miyauchi, K., Toyama, S., Nambu, A., Oboki, K., Ohno, T., Motomura, K., Matsuda, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.021 · Cited by 274
Role of IL‐25, IL‐33, and TSLP in triggering united airway diseases toward type 2 inflammation
Hong, H., Liao, S., Chen, F., Yang, Q., & Wang, D. (2020) · Allergy · doi:10.1111/all.14526 · Cited by 272
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 272
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Abraham Gnanadass, S., Divakar Prabhu, Y., & Valsala Gopalakrishnan, A. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 272
Johnson, K. E., Chikoti, L., & Chandran, B. (2013) · Journal of Virology · doi:10.1128/jvi.00082-13 · Cited by 271
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Cohen, E. S., Scott, I. C., Majithiya, J. B., Rapley, L., Kemp, B. P., England, E., Rees, D. G., Overed-Sayer, C. L., Woods, J., Bond, N. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9327 · Cited by 270
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Epithelial decision makers: in search of the 'epimmunome'
Swamy, M., Jamora, C., Havran, W., & Hayday, A. (2010) · Nature Immunology · doi:10.1038/ni.1905 · Cited by 269
Pathogenic mechanisms of pancreatitis
Manohar, M., Verma, A. K., Venkateshaiah, S. U., Sanders, N. L., & Mishra, A. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i1.10 · Cited by 269
IL‐1: Discoveries, controversies and future directions
Dinarello, C. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040319 · Cited by 268
IRAK1: A critical signaling mediator of innate immunity
Gottipati, S., Rao, N. L., & Fung-Leung, W.-P. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.009 · Cited by 268
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Verri, W. A., Souto, F. O., Vieira, S. M., Almeida, S. C. L., Fukada, S. Y., Xu, D., Alves-Filho, J. C., Cunha, T. M., Guerrero, A. T. G., Mattos-Guimaraes, R. B., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122655 · Cited by 263
Regulation of Mast Cell Responses in Health and Disease
Gilfillan, A. M., & Beaven, M. A. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i6.30 · Cited by 259
Novel biomarkers for cardiovascular risk prediction.
Wang, J., Tan, G.-J., Han, L.-N., Bai, Y., He, M., & Liu, H. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.02.008 · Cited by 256
Unique Action of Interleukin-18 on T Cells and Other Immune Cells
Nakanishi, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00763 · Cited by 256
Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression
Taniguchi, S., Elhance, A., Van Duzer, A., Kumar, S., Leitenberger, J. J., & Oshimori, N. (2020) · Science · doi:10.1126/science.aay1813 · Cited by 256
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
IL-33/ST2 axis in inflammation and immunopathology
Milovanovic, M., Volarevic, V., Radosavljevic, G., Jovanovic, I., Pejnovic, N., Arsenijevic, N., & Lukic, M. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8283-9 · Cited by 256
Ballak, D. B., Stienstra, R., Tack, C. J., Dinarello, C. A., & van Diepen, J. A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.005 · Cited by 255
First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment
Saluzzo, S., Gorki, A.-D., Rana, B. M. J., Martins, R., Scanlon, S., Starkl, P., Lakovits, K., Hladik, A., Korosec, A., Sharif, O., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.071 · Cited by 255
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Talabot-Ayer, D., Lamacchia, C., Gabay, C., & Palmer, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901744200 · Cited by 252
Interleukin-18 and the Pathogenesis of Inflammatory Diseases
Dinarello, C. A. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.09.013 · Cited by 252
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
Marvie, P., Lisbonne, M., L’Helgoualc’h, A., Rauch, M., Turlin, B., Preisser, L., Bourd‐Boittin, K., Théret, N., Gascan, H., Piquet‐Pellorce, C., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00801.x · Cited by 251
“IL-33 is also involved in the induction of the Th2 response to intestinal helminth infection in vivo [8].”
BackgroundInfluentialVan Dyken, S. J., Mohapatra, A., Nussbaum, J. C., Molofsky, A. B., Thornton, E. E., Ziegler, S. F., McKenzie, A. N. J., Krummel, M. F., Liang, H.-E., & Locksley, R. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.003 · Cited by 251
“Exogenous administration or transgenic expression of any of these epithelial cytokines results in exaggerated type 2 immune pathology in the lung, suggesting roles in the initiation of allergic immunity (Fort et al., 2001; Schmitz et al., 2005; Zhou et al., 2005).”
BackgroundT cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation
Allakhverdi, Z., Comeau, M. R., Smith, D. E., Toy, D., Endam, L. M., Desrosiers, M., Liu, Y.-J., Howie, K. J., Denburg, J. A., Gauvreau, G. M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.022 · Cited by 234
A critical role of IL-33 in experimental allergic rhinitis
Haenuki, Y., Matsushita, K., Futatsugi-Yumikura, S., Ishii, K. J., Kawagoe, T., Imoto, Y., Fujieda, S., Yasuda, M., Hisa, Y., Akira, S., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.013 · Cited by 233
The interleukin-1 receptor family
Boraschi, D., & Tagliabue, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.023 · Cited by 227
Palm, N. W., Rosenstein, R. K., Yu, S., Schenten, D. D., Florsheim, E., & Medzhitov, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.006 · Cited by 214
Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation
Li, J., Razumilava, N., Gores, G. J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y.-H., Glaser, S. S., Shivakumar, P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73742 · Cited by 202
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
Chapuis, J., Hot, D., Hansmannel, F., Kerdraon, O., Ferreira, S., Hubans, C., Maurage, C. A., Huot, L., Bensemain, F., Laumet, G., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.10 · Cited by 201
SAMP1/YitFc mouse strain: A spontaneous model of Crohnʼs disease-like ileitis
Pizarro, T. T., Pastorelli, L., Bamias, G., Garg, R. R., Reuter, B. K., Mercado, J. R., Chieppa, M., Arseneau, K. O., Ley, K., & Cominelli, F. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21638 · Cited by 192
IL-33 and IL-33 receptors in host defense and diseases
Oboki, K., Ohno, T., Kajiwara, N., Saito, H., & Nakae, S. (2010) · Allergology International · doi:10.2332/allergolint.10-rai-0186 · Cited by 190
Vannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1938 · Cited by 188
Cardiac Nonmyocytes in the Hub of Cardiac Hypertrophy
Kamo, T., Akazawa, H., & Komuro, I. (2015) · Circulation Research · doi:10.1161/circresaha.117.305349 · Cited by 171
IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma
Smith, D. E. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03384.x · Cited by 173
Aberrant immune responses in a mouse with behavioral disorders
Heo, Y., Zhang, Y., Gao, D., Miller, V. M., & Lawrence, D. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020912 · Cited by 168
Alternative splicing of interleukin-33 and type 2 inflammation in asthma
Gordon, E. D., Simpson, L. J., Rios, C. L., Ringel, L., Lachowicz-Scroggins, M. E., Peters, M. C., Wesolowska-Andersen, A., Gonzalez, J. R., MacLeod, H. J., Christian, L. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601914113 · Cited by 153
Moreira, A. P., & Hogaboam, C. M. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0027 · Cited by 139
The Interleukin‐1 Receptor Family
Boraschi, D., & Tagliabue, A. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74009-2 · Cited by 133
Bhaumik, S., & Basu, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00254 · Cited by 119
Cardiokines: recent progress in elucidating the cardiac secretome
Shimano, M., Ouchi, N., & Walsh, K. (2012) · Circulation · doi:10.1161/circulationaha.112.150656 · Cited by 116
Lamkanfi, M., & Dixit, V. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.011 · Cited by 116
IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity
Zaiss, M. M., Maslowski, K. M., Mosconi, I., Guenat, N., Marsland, B. J., & Harris, N. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003531 · Cited by 116
Lau, S.-F., Chen, C., Fu, W.-Y., Qu, J. Y., Cheung, T. H., Fu, A. K. Y., & Ip, N. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107530 · Cited by 114
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
Dendritic Cells: Critical Regulators of Allergic Asthma
Morianos, I., & Semitekolou, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217930 · Cited by 102
Krumm, B., Xiang, Y., & Deng, J. (2014) · Protein Science · doi:10.1002/pro.2441 · Cited by 95
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
Imai, J., Kitamoto, S., Sugihara, K., Nagao-Kitamoto, H., Hayashi, A., Morhardt, T. L., Kuffa, P., Higgins, P. D. R., Barnich, N., & Kamada, N. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0138-4 · Cited by 91
Defining the Microglia Response during the Time Course of Chronic Neurodegeneration
Vincenti, J. E., Murphy, L., Grabert, K., McColl, B. W., Cancellotti, E., Freeman, T. C., & Manson, J. C. (2016) · Journal of Virology · doi:10.1128/jvi.02613-15 · Cited by 88
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
“IL-33 is expressed by epithelial cells, endothelial cells, fibroblasts and smooth muscle cells [101-103], as well as by mast cells after IgE-mediated activation [104].”
BackgroundIshiguro, N., Moriyama, M., Furusho, K., Furukawa, S., Shibata, T., Murakami, Y., Chinju, A., Haque, A. S. M. R., Gion, Y., Ohta, M., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41052 · Cited by 86
Jafarzadeh, A., & Nemati, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.003 · Cited by 84
IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
Gao, Y., Liu, Y., Yang, M., Guo, X., Zhang, M., Li, H., Li, J., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9259 · Cited by 79
IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
Saresella, M., Marventano, I., Piancone, F., La Rosa, F., Galimberti, D., Fenoglio, C., Scarpini, E., & Clerici, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01806-4 · Cited by 75
Lee, J.-U., Chang, H. S., Lee, H. J., Jung, C. A., Bae, D. J., Song, H. J., Park, J. S., Uh, S.-T., Kim, Y. H., Seo, K.-H., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0380-z · Cited by 73
Alarmin cytokines as central regulators of cutaneous immunity
Hasegawa, T., Oka, T., & Demehri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876515 · Cited by 70
Abston, E. D., Barin, J. G., Cihakova, D., Bucek, A., Coronado, M. J., Brandt, J. E., Bedja, D., Kim, J. B., Georgakopoulos, D., Gabrielson, K. L., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963769 · Cited by 69
Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease
Yu, J.-T., Song, J.-H., Wang, N.-D., Wu, Z.-C., Zhang, Q., Zhang, N., Zhang, W., Xuan, S.-Y., & Tan, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.003 · Cited by 54
Innate Control of Tissue-Reparative Human Regulatory T Cells
Lam, A. J., MacDonald, K. N., Pesenacker, A. M., Juvet, S. C., Morishita, K. A., Bressler, B., iGenoMed Consortium, Pan, J. G., Sidhu, S. S., Rioux, J. D., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801330 · Cited by 47
Efficacy of biologics in atopic dermatitis
Wu, J., & Guttman-Yassky, E. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1722998 · Cited by 46
Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis
Choi, H. S., Won, T., Hou, X., Chen, G., Bracamonte-Baran, W., Talor, M. V., Jurčová, I., Szárszoi, O., Čurnova, L., Stříž, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.040 · Cited by 43
Serum amyloid A induces interleukin‐33 expression through an IRF7‐dependent pathway
Sun, L., Zhu, Z., Cheng, N., Yan, Q., & Ye, R. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344310 · Cited by 41
Sobotta, S., Raue, A., Huang, X., Vanlier, J., Jünger, A., Bohl, S., Albrecht, U., Hahnel, M. J., Wolf, S., Mueller, N. S., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00775 · Cited by 28
“This IL-1-like cytokine (Schmitz et al., 2005) was described to be induced in fibrotic livers, and hepatic stellate cells were suggested as major IL-33 producer in this context (Marvie et al., 2010).”
BackgroundSharma, S. R., Choudhary, S. K., Vorobiov, J., Commins, S. P., & Karim, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1336883 · Cited by 23
Abukabda, A. B., McBride, C. R., Batchelor, T. P., Goldsmith, W. T., Bowdridge, E. C., Garner, K. L., Friend, S., & Nurkiewicz, T. R. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0280-2 · Cited by 22
Tsuji, G., Yamamura, K., Kawamura, K., Kido-Nakahara, M., Ito, T., & Nakahara, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914633 · Cited by 21
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Tamari, M., & Ver Heul, A. M. (2025) · Allergology International · doi:10.1016/j.alit.2025.02.001 · Cited by 17
Structural basis for IL-33 recognition and its antagonism by the helminth effector protein HpARI2
Jamwal, A., Colomb, F., McSorley, H. J., & Higgins, M. K. (2024) · Nature Communications · doi:10.1038/s41467-024-49550-0 · Cited by 15
The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation
Korkmaz, R. Ü., Omony, J., Tan, X., Klotz, M., Dragunas, G., Chen, S., Shankhwar, S., Ertüz, Z., Müller, C., Ragab, M., et al. (2026) · Allergy · doi:10.1111/all.70121 · Cited by 4
Metadata
- Authors
- Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., & Kastelein, R. A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 23
- Issue
- 5
- Pages
- 479-490
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2157710399
- Cited by
- 3,710
- References
- 48
- FWCI
- 20.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.